Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-F Nicolas

Showing results (261-270 of 263) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 263 results.
Transfusion|February 13, 2019
Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patientsO Hequet, S Poutrel, P Connes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2025
Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAbG U Machado, V Bourdenet, G Devouassoux, et al.
Clinical and Translational Allergy|September 25, 2023
A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiativeTorsten Zuberbier, Amir Abdul Latiff, Xenofon Aggelidis, et al.
Pageof 27

Showing results (261-270 of 263) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 263 results.
Transfusion|February 13, 2019
Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patientsO Hequet, S Poutrel, P Connes, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 29, 2025
Eczema following IL-5 inhibitors for the treatment of severe asthma with improvement after switching to an IL-4Rα mAbG U Machado, V Bourdenet, G Devouassoux, et al.
Clinical and Translational Allergy|September 25, 2023
A concept for integrated care pathways for atopic dermatitis-A GA<sup>2</sup> LEN ADCARE initiativeTorsten Zuberbier, Amir Abdul Latiff, Xenofon Aggelidis, et al.
Pageof 27